New agents for orthopaedic thromboprophylaxis: caution essential, but time will tell.
Verma
Abhishek K
AK
Department of Vascular Surgery, Gosford Hospital, Gosford, New South Wales, Australia.
D000925:Anticoagulants / Q000627:therapeutic use*; D001562:Benzimidazoles / Q000627:therapeutic use*; D000069604:Dabigatran; D017984:Enoxaparin / Q000627:therapeutic use; D006801:Humans; D009025:Morpholines / Q000627:therapeutic use*; D019637:Orthopedic Procedures; D011183:Postoperative Complications / Q000517:prevention & control*; D011725:Pyridines / Q000627:therapeutic use*; D000069552:Rivaroxaban; D013876:Thiophenes / Q000627:therapeutic use*; D054556:Venous Thromboembolism / Q000517:prevention & control*
D000925:Anticoagulants; D001562:Benzimidazoles; D017984:Enoxaparin; D009025:Morpholines; D011725:Pyridines; D013876:Thiophenes; D000069552:Rivaroxaban; D000069604:Dabigatran